The headlines made federal rescheduling sound like the walls were coming down. For a licensed California operator, nearly every wall is still standing: the state license, the track-and-trace system, the lab, the packaging rules, the excise return, the bank, and the state line. Rescheduling changed one federal layer for part of the industry. For some operators, it added a new one.
Here is what changed, what did not, and what each layer still costs in records, cash, and staff time.
What changed at the federal level
A Department of Justice final order published April 28, 2026, placed two categories of marijuana in Schedule III: FDA-approved drug products containing marijuana, and marijuana subject to a state medical marijuana license (91 Fed. Reg. 22714). Adult-use and unlicensed marijuana remain in Schedule I.
The same order created a DEA registration pathway for state medical licensees. A registration cannot exceed the scope of the state license, and it is suspended automatically if the state license is suspended, revoked, or expires (21 C.F.R. §1301.13(k), as added by the order). Registered distributors may transfer product only to other registrants, so a registrant’s suppliers and customers matter too.
Broader rescheduling is still open. The DEA hearing on it began June 29, 2026. As of this writing, no recommended decision has issued.
What it costs: a medical operator that registers now answers to a second regulator, with its own application, records, and inventory obligations. Whether to register is a question for your regulatory counsel; the financial side is modeling what it changes in staffing, supply chain, and tax.
State licensing: still the foundation
Commercial cannabis activity in California still runs on a Department of Cannabis Control (DCC) license, and cities and counties keep the power to regulate or ban licensed businesses locally (Bus. & Prof. Code §26200(a)(1)).
Rescheduling has already reshaped licensing. DCC emergency regulations effective June 4, 2026, let retailers hold separate adult-use (A) and medicinal (M) licenses at the same premises, including through a related entity, and convert an existing dual-designation license (Cal. Code Regs., tit. 4, §§15000.1, 15000.2, 15023.1). Separate entities at one premises are jointly and severally liable for each other’s obligations, and a newly converted M license must obtain its own inventory. The emergency rules are set to expire December 2, 2026, unless DCC extends or replaces them.
What it costs: a second entity means a second set of books, a separate seller’s permit and cannabis retailer excise tax permit for each entity (according to CDTFA), separate inventory, more monthly filings, and a second annual license fee at renewal.
Track-and-trace: still daily
California’s track-and-trace system (CCTT) did not get any lighter. Licensees must record incoming shipments, production, destruction, lab tests, and sales within 24 hours of each activity (Cal. Code Regs., tit. 4, §15049(b)). A DCC rulemaking noticed June 5, 2026 (DCC-2026-02-R) would go further, requiring retailers to record price, discounts, excise, local taxes, and sales tax on each sale, and tightening how transfers are approved.
What it costs: daily data entry by trained staff, plus a monthly reconciliation of track-and-trace, POS, and the general ledger. When those three disagree, the gap usually surfaces as an inventory problem at year-end. Strong inventory accounting is how you find it first.
Testing, packaging, and labeling: still per batch
State law still calls for testing before cannabis reaches retailers, and for destruction of noncompliant batches unless remediation is allowed (Bus. & Prof. Code §26104(b)). DCC’s new pesticide testing regulations took effect October 1, 2026. Packages headed for retail sale must still be child-resistant (Cal. Code Regs., tit. 4, §17412), with packaging and labeling rules rooted in Bus. & Prof. Code §26120.
What it costs: lab fees, product sitting on hold while results come back, write-offs when a batch fails, and packaging redesigns when rules change. Each one hits margin and ties up cash.
Excise and local taxes: still collected at the counter
California retailers still collect the cannabis excise tax from customers and remit it to CDTFA (Rev. & Tax. Code §34011.2(c)). CDTFA states the rate is 15 percent of gross receipts from October 1, 2025, through June 30, 2029. The excise tax is included in the sales tax base. Patients with a valid Medical Marijuana Identification Card and government ID are exempt from sales and use tax, but CDTFA says that exemption does not apply to the excise tax. Federal rescheduling did not change any of this.
Local taxes stack on top. Counties may tax licensed cannabis activity (Rev. & Tax. Code §34021.5), and many cities impose their own. If you pass a local cannabis business tax through on the receipt, CDTFA applies excise and sales tax to that amount too.
What it costs: cash that is not yours. In a hypothetical month with $100,000 of gross receipts subject to excise, a retailer collects $15,000 in excise alone (15 percent of $100,000), before sales tax and local tax. Left in the operating account, that money looks like working capital until the return is due.
Banking: still restricted
Banks still look to FinCEN’s 2014 guidance on marijuana-related businesses, which says a bank’s obligation to file suspicious activity reports is unaffected by state legalization (FinCEN, FIN-2014-G001). Federal cannabis banking legislation was reintroduced in June 2026 (SAFE Banking Act of 2026, H.R. 9471) and, as of this writing, has not become law. A business that receives more than $10,000 in cash in one transaction or related transactions still files IRS Form 8300 (IRC §6050I).
What it costs: account fees, cash handling and transport, deposit reconciliation, and the financial statements and cash records banks request at every review. More in When the Bank Says No.
State lines: still closed
California law still does not authorize a licensee to transport or distribute cannabis outside the state, except under a separate interstate-agreement framework (Bus. & Prof. Code §26080(a)). In a 2023 opinion, the California Attorney General concluded that state authorization of commerce with out-of-state licensees could create significant legal risk under the federal Controlled Substances Act (Cal. Att’y Gen. Op. No. 23-103). And a federal registration cannot reach beyond the state license behind it.
What it costs: your market is still California only, which caps volume and keeps price pressure local. Any plan that assumes out-of-state sales needs your regulatory counsel’s sign-off before it goes into a forecast.
Federal income tax: still split
Adult-use activity remains in Schedule I, so §280E still applies to it, and as of this writing Treasury and the IRS had not issued detailed rules for operators with both medical and adult-use sales. California does not follow §280E for licensees (Rev. & Tax. Code §17209). For the details, see Section 280E After the 2026 Partial Rescheduling.
What to keep doing
- Reconcile monthly. Tie track-and-trace, POS, and the general ledger together by license every month.
- Set aside tax cash. Hold excise, sales, and local tax collections apart from operating cash, and reconcile the balance to each return.
- Keep medical and adult-use apart. Track sales, inventory, labor, and shared costs by activity now, whether or not you split licenses.
- Budget compliance as a real cost. Give testing, packaging, track-and-trace labor, and permit fees their own budget lines, so margins reflect them.
- Stay bank-ready. Close the books on time each month, so statements and cash records are ready when the bank asks.
- Forecast California only. Build cash flow forecasts on today’s rules, and run rescheduling scenarios separately.
- Watch the calendar. The DCC emergency rules (set to expire December 2, 2026), the DEA proceeding, Treasury guidance, and the excise rate are all still moving.
How TreeStar can help
The TreeStar team can help cannabis operators keep every layer reconciled: bookkeeping and inventory accounting tied to track-and-trace, excise and cash records that match the returns, tax preparation and planning (including §280E), and financial modeling and cash flow planning for rescheduling scenarios. We work on the financial side alongside your attorney and regulatory counsel, never in their place. Learn more about our cannabis accounting and tax work.
This article is general information, not advice for your situation. Rules change; confirm current law before acting.
